2017 Phoenix Clinical Research Fair Program of Events
|
|
- Charlotte Gibbs
- 6 years ago
- Views:
Transcription
1 2017 Phoenix Clinical Research Fair Program of Events From 8:45 a.m. Check-in Second Floor of the Conference Center 8:45 a.m. 1:00 p.m. Trial Exhibition Second Floor of the Conference Center 9:30 a.m. 11:30 a.m. Plenary Session Partnering Toward Cures for PD Second Floor of the Conference Center Moderator Sohini Chowdhury, The Michael J. Fox Foundation 1:00 p.m. Event Ends Panelists Patti Meese, Person with Parkinson s, Phoenix Resident Mary Higgins, RN, Clinical Research Coordinator, Barrow Neurological Institute Dr. David Shprecher, DO, Movement Disorders Director, Banner Sun Health
2 One Clinical study visit at a time, you can help speed research that could transform millions of lives. Since The Michael J. Fox Foundation for Parkinson s Research (MJFF) opened its doors in 2000, we have been unwavering in our commitment to finding new therapies and, ultimately, a cure for Parkinson s. With the robust pipeline of therapies in development, the future has never looked brighter. However, there are still obstacles in our path to new treatments for Parkinson s disease (PD). Chief among these challenges is the need for participants to fill clinical trials. No amount of money can get us to a cure without volunteers like you people with and without Parkinson s. In coming here today to learn more about clinical research participation, you have demonstrated your commitment to accelerating progress in better understanding PD and testing new therapies. I, along with my colleagues at MJFF, am overwhelmed by your willingness and enthusiasm to be part of this critical work. One clinical study visit at a time, you can help speed research that could transform millions of lives. We hope that you walk away from today s Clinical Research Fair with the name of at least one study in which you may enroll and the knowledge that you can continue to find opportunities to participate in research by registering for the MJFF online clinical trial matching tool Fox Trial Finder. Thank you for participating in the Phoenix Clinical Research Fair and for your commitment to accelerating PD research. With deep gratitude, Sohini Chowdhury Deputy CEO The Michael J. Fox Foundation
3 Arizona State University Opportunities to Participate in PD Research Trial: Dual Tasking and Protective Stepping in People with Parkinson's Disease Focus: Symptomatic physical rehabilitation Trial: Perception of dysarthric speech Type: Observational Focus: Symptomatic - speech Banner Sun Health Research Institute Trial: Arizona Study of Aging and Neurodegenerative Disorders Type: Observational Focus: Biomarkers Trial: Progressive Supranuclear Palsy Trial (BMS CN002-12) Focus: Biomarkers & disease modifying Trial: Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects with Lewy Body Dementia (LBD) or Parkinson s Disease Dementia (PDD) Focus: Symptomatic - sleep disturbances Barrow Neurological Institute Trial: Deep Brain Stimulation of the nbm to Treat Mild Cognitive Impairment in Parkinson's Disease Focus: Symptomatic - cognition Trial: Deep Brain Stimulation (DBS) Database Focus: Symptomatic - outcomes following DBS Trial: Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability and Fall Risk Reduction in PD Focus: Symptomatic freezing of gait and balance Muhammad Ali Movement Disorder Center Trial: A Study to Evaluate the Efficacy of RO in Participants With Early Parkinson's Disease (PASADENA) Focus: Disease modifying Trial: A Study to Assess the Efficacy and Safety of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients (Accordance) Focus: Symptomatic - motor fluctuations, reducing off time Trial: Nilotinib in Parkinson s Disease (NILO-PD) Focus: Symptomatic Trial: Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease Focus: Disease modifying University of Arizona Health Sciences Trial: RESTORE: A clinical study of patients with symptomatic neurogenic orthostatic hypotension to assess Sustained effects Of droxidopa therapy Focus: Symptomatic - symptom management Trial: Effect of LY on Cognition in Mild-to- Moderate Parkinson Disease Dementia Focus: Symptomatic - cognition The Michael J. Fox Foundation Trial: Fox Insight Web Study of Day-to-Day Health Type: Observational and web-based Focus: Patient preferences & experiences Website:
4 Research Team Directory Arizona State University Name: Daniel Peterson, PhD Title: Assistant Professor Name: Visar Berisha, PhD Title: Assistant Professor Banner Sun Health Research Institute Name: Terry Fogerty Title: Clinical Trial Events Coordinator Name: Molly Goddard Title: Clinical Research Coordinator Name: David Shprecher, DO Msci Title: Movement Disorders Director Barrow Neurological Institute Name: Meg Lambert, BSN, RN, CNRN Title: Deep Brain Stimulation Program Coordinator Name: Peg McAuley, RN, CNRN Title: Falls Program Coordinator Muhammad Ali Movement Disorder Center Name: Giulia Andrews Title: Research Assistant Name: Mary Harrigan Title: Clinical Research Coordinator Name: Catherine Richard Title: Clinical Research Specialist University of Arizona Health Sciences Name: Kayla Darris Title: Research Coordinator Name: Derek Gin Title: Research Coordinator Name: Eddie Soto Title: Research Technician PMDAlliance Name: Andrea Merriam Title: Director of Community Engagement The Michael J. Fox Foundation Fox Trial Finder Fox Insight Web Study Support
5 NOTES:
6
7
8
EXPLORING OPPORTUNITIES TO PARTNER TOWARD CURES FOR PD. Chicago Clinical Research Fair June 11, 2016
EXPLORING OPPORTUNITIES TO PARTNER TOWARD CURES FOR PD Chicago Clinical Research Fair June 11, 2016 HOW DO WE LEARN MORE ABOUT PARKINSON S DISEASE? Patient-reported data Diagnosis and clinical symptoms
More informationINTRODUCTION TO FOX TRIAL FINDER. Accelerating Clinical Trial Recruitment Online
INTRODUCTION TO FOX TRIAL FINDER Accelerating Clinical Trial Recruitment Online MJFF WAS FOUNDED WITH CLEAR OBJECTIVES Drive the best Parkinson s disease research Deliver improved therapies and a cure
More informationDisclaimer. Dialogue with a Patient 3/18/2016
Medical Affairs and Scientific Communications 2016 Annual Forum Dialogue with a Patient Bill Wilkins, Co-Founder, Executive Director, Wilkins Parkinsons Foundation March 21-23 Kissimmee, FL Disclaimer
More informationTHE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH. Funding Opportunities
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH Funding Opportunities AGENDA 1. Brief Overview of MJFF Philosophy 2. MJFF Funding Programs 3. How to apply 4. What happens next? 5. Q&A Please feel
More informationParkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee
Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is
More informationTreatment of Parkinson s Disease: Present and Future
Treatment of Parkinson s Disease: Present and Future Karen Blindauer, MD Professor of Neurology Director of Movement Disorders Program Medical College of Wisconsin Neuropathology: Loss of Dopamine- Producing
More informationWHO, WHAT, WHEN AND WHERE OF PARKINSON S DIAGNOSIS. MJFF Third Thursdays Webinar March 17, 2016
WHO, WHAT, WHEN AND WHERE OF PARKINSON S DIAGNOSIS MJFF Third Thursdays Webinar March 17, 2016 WHAT WE LL COVER TODAY How is Parkinson s misdiagnosed? How is Parkinson s diagnosed today? Can we use DaTscan
More informationUPDATE ON RESEARCH IN PARKINSON S DISEASE
UPDATE ON RESEARCH IN PARKINSON S DISEASE Charles H. Adler, M.D., Ph.D. Professor of Neurology Mayo Clinic College of Medicine Co-Principal Investigator Arizona Parkinson s Disease Consortium Arizona Study
More informationDesigning patient-centered clinical trials: Results of the MDIC project to use patient preference information to design clinical trials
1 Informative series of workshops featuring emerging trends in medical technology regulatory science, MDIC projects and subject matter experts sharing perspectives, progress and opportunities. Designing
More informationWelcome to today s webinar
Welcome to today s webinar We will begin the webinar at 2:00 p.m. Eastern All attendee lines are automatically muted. This webinar is being recorded and will be posted on LBDA s Youtube page. Throughout
More informationParkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s
Parkinson s Disease Update Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s What is a movement disorder? Neurological disorders that affect ability to move by causing
More informationSUPPORT FEDERAL FUNDING FOR PARKINSON S DISEASE RESEARCH AND DRUG DEVELOPMENT
SUPPORT FEDERAL FUNDING FOR PARKINSON S DISEASE RESEARCH AND DRUG DEVELOPMENT Parkinson s disease (PD) affects an estimated 750,000 to 1 million Americans. Currently, there is no treatment to slow, stop
More informationAppendix N: Research recommendations
Appendix N: recommendations N.1 First-line treatment of motor symptoms recommendation 1 Interventions What is the effectiveness of initial levodopa monotherapy versus initial levodopa-dopamine agonist
More informationMJFF S VISION FOR PARTNERING WITH PATIENTS. Sohini Chowdhury The Michael J. Fox Foundation
MJFF S VISION FOR PARTNERING WITH PATIENTS Sohini Chowdhury The Michael J. Fox Foundation OUR SINGLE, URGENT GOAL: CURE PARKINSON S DISEASE MJFF s Mission The Michael J. Fox Foundation is dedicated to
More informationOptimizing Clinical Communication in Parkinson s Disease:
Optimizing Clinical Communication in Parkinson s Disease:,Strategies for improving communication between you and your neurologist PFNCA Symposium March 25, 2017 Pritha Ghosh, MD Assistant Professor of
More informationWelcome and Introductions
Parkinson s Disease Spotlight on Treatment Advances Tuesday, January 26, 2016 Welcome and Introductions Stephanie Paul Vice President Development and Marketing American Parkinson Disease Association 1
More informationIII./3.1. Movement disorders with akinetic rigid symptoms
III./3.1. Movement disorders with akinetic rigid symptoms III./3.1.1. Parkinson s disease Parkinson s disease (PD) is the second most common neurodegenerative disorder worldwide after Alzheimer s disease.
More informationUSING PRECISION MEDICINE TO HELP PATIENTS WITH PARKINSON S DISEASE. The Michael J. Fox Foundation for Parkinson s Research
USING PRECISION MEDICINE TO HELP PATIENTS WITH PARKINSON S DISEASE The Michael J. Fox Foundation for Parkinson s Research MJFF IS THE WORLD S LARGEST NONPROFIT FUNDER OF PD RESEARCH Our Mission We are
More informationParkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder
Prevalence Parkinson s Disease Mark S. Baron, M.D. Associate Professor of Neurology Movement Disorders Section VCU School of Medicine Common disorder Approaching 1% by 65 yrs of age, 2% by 80 yrs of age
More informationMAXIMIZING FUNCTION IN PARKINSON S DISEASE
1 MAXIMIZING FUNCTION IN PARKINSON S DISEASE September 13, 2016 End Falls This Falls Conference Jan Goldstein Elman One Step Ahead Mobility Toronto, Ontario Outline An overview of Parkinson s disease (PD):
More informationParkinson s Foundation Nurse Course Faculty
* Planning Committee Parkinson s Foundation Nurse Course Faculty * Julie Carter, RN, MN, ANP Ms. Carter is a nurse practitioner and Professor of Neurology at Oregon Health and Science University. She received
More informationThe effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review
The effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review Erica Tilley Master of Clinical Science Joanna Briggs Institute Faculty of
More informationSupportive Neurology: Valuing Increased Function and Improved QoL in Treatment of Non-Core Symptoms of Neurological Disease
Supportive Neurology: Valuing Increased Function and Improved QoL in Treatment of Non-Core Symptoms of Neurological Disease Ginger S. Johnson, PhD Vice President Defined Health Todd Sherer, PhD Chief Executive
More informationDeep Brain Stimulation: Indications and Ethical Applications
Deep Brain Stimulation Overview Kara D. Beasley, DO, MBe, FACOS Boulder Neurosurgical and Spine Associates (303) 562-1372 Deep Brain Stimulation: Indications and Ethical Applications Instrument of Change
More informationBarrow, Phoenix Fire Announce Partnership Revolutionizing Stroke Treatment
PRINT Barrow, Phoenix Fire Announce Partnership Revolutionizing Stroke Treatment Press Releases June 14, 2017 Comments (0) Barrow Neurological Institute and the Phoenix Fire Department today announced
More informationWelcome and Introductions
Parkinson s Disease Spotlight on Addressing Motor and Non-Motor Symptoms The Changing Landscape Wednesday, March 8, 2017 Welcome and Introductions Stephanie Paul Vice President Development and Marketing
More informationSince 1982, NPF has funded more than $155 million in research and support services.
Sponsor Handbook 1 Welcome Thank you for sponsoring the National Parkinson Foundation s inaugural Moving Day walk event. Your commitment to helping us in raising much-needed funds to support NPF s mission
More informationDate of Referral: Enhanced Primary Care Pathway: Parkinson s Disease
Specialist LINK Linking Physicians CALGARY AND AREA Patient Name: Date of Birth: Calgary RHRN: PHN / ULI: Date of Referral: Referring MD: Fax: Today s Date: CONFIRMATION: TRIAGE CATEGORY: REFERRAL STATUS:
More informationFaculty. Joseph Friedman, MD
Faculty Claire Henchcliffe, MD, DPhil Associate Professor of Neurology Weill Cornell Medical College Associate Attending Neurologist New York-Presbyterian Hospital Director of the Parkinson s Institute
More informationOverview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits
Overview Overview Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits The differential diagnosis of Parkinson s disease Primary vs. Secondary Parkinsonism Proteinopathies:
More informationWhat is Parkinson s Disease?
2018 Update in Parkinson s Disease: Treatments and Future Plans Arita McCoy, MSN, CRNP Johns Hopkins Parkinson s Disease and Movement Disorder Center A National Parkinson Foundation Center of Excellence
More informationParkinson's Disease KP Update
Parkinson's Disease KP Update Andrew Imbus, PA-C Neurology, Movement Disorders Kaiser Permanente, Los Angeles Medical Center No disclosures "I often say now I don't have any choice whether or not I have
More informationSPONSORSHIP OPPORTUNITIES
SPONSORSHIP OPPORTUNITIES 2018 WHAT IS HYDROCEPHALUS? Hydrocephalus is caused by an imbalance in the production and absorption of cerebral spinal fluid in the brain which causes the ventricles to enlarge.
More informationThe Michael J. Fox Foundation & Gecko Ventures: The Parkinson s Disease Data Challenge
The Michael J. Fox Foundation & Gecko Ventures: The Parkinson s Disease Data Challenge Sohini Chowdhury, Michael J. Fox Foundation Alex Vannoni, Gecko Ventures, Johns Hopkins Bloomberg School of Public
More informationADVANCES IN PARKINSON S DISEASE: A MULTIDISCIPLINARY APPROACH SATURDAY, OCTOBER 7, :30 A.M. 5:00 P.M.
ADVANCES IN PARKINSON S DISEASE: A MULTIDISCIPLINARY APPROACH SATURDAY, OCTOBER 7, 2017 7:30 A.M. 5:00 P.M. This conference will explore the challenges and opportunities facing clinicians and healthcare
More informationFALLs in Parkinson s Disease (PD)
FALLs in Parkinson s Disease (PD) By: Justin Martello, MD Christiana Care Neurology Specialists Adapted from slides by: Stephen Grill, MD, PHD Objectives 1. What is a fall? 2. Fall Ex s. 3. Gait and Types
More informationSurgical Management of Parkinson s Disease
Surgical Management of Parkinson s Disease Shyamal H. Mehta MD, PhD Assistant Professor of Neurology, Movement Disorders Division Mayo Clinic College of Medicine Mayo Clinic, Arizona 2016 MFMER slide-1
More informationWHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019
WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019 YOUNG ONSET PARKINSON S DISEASE Definition: Parkinson s disease diagnosed
More informationSTUDIES TO SLOW OR STOP PARKINSON S DISEASE. MJFF Third Thursdays Webinar October 15, 2015
STUDIES TO SLOW OR STOP PARKINSON S DISEASE MJFF Third Thursdays Webinar October 15, 2015 WHAT WE LL COVER TODAY What are the varied approaches to stop Parkinson s? How can our immune system help fight
More informationEnhanced Primary Care Pathway: Parkinson s Disease
Enhanced Primary Care Pathway: Parkinson s Disease 1. Focused summary of PD relevant to primary care Parkinson s Disease (PD) and Essential tremor (ET) are two of the most common movement disorders encountered
More informationThe 8 th Walk For A Vision of Hong Kong Sanatorium & Hospital Unfreezing Gaits for Patients with Parkinson s Disease
For immediate release The 8 th Walk For A Vision of Hong Kong Sanatorium & Hospital Unfreezing Gaits for Patients with Parkinson s Disease (13 March 2016 Hong Kong) More than 200 runners and well-wishers
More informationEvaluation and Management of Parkinson s Disease in the Older Patient
Evaluation and Management of Parkinson s Disease in the Older Patient David A. Hinkle, MD, PhD Comprehensive Movement Disorders Clinic Pittsburgh Institute for Neurodegenerative Diseases University of
More informationG8 Dementia Summit. Joint Opening Plenary
G8 Dementia Summit Joint Opening Plenary London, 11 December 2013 Speech by Yves Leterme Deputy Secretary-General, OECD 0 Secretary of State Jeremy Hunt, Director General of the World Health Organisation
More informationPARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease
5/11/16 PARKINSON S DISEASE Parkinson s disease Prevalence increases with age (starts 40s60s) Seen in all ethnic groups, M:F about 1.5:1 Second most common neurodegenerative disease Genetics role greater
More informationThe Dementia Community Awareness Programme: Understand Together Campaign & Dementia Elevator Project
The Dementia Community Awareness Programme: Understand Together Campaign & Dementia Elevator Project Ann-Marie Coen Dementia Elevator Project, Dublin City University What is the Dementia Community Awareness
More informationIt All Begins with Awareness...
Awareness builds knowledge. Knowledge builds power. Power builds research. Research builds treatment. Treatment builds hope It All Begins with Awareness... 2011 LBD Awareness Toolkit For more information
More informationA Million Hands. Social Action Partnership September 2019 to July 2022
A Million Hands Social Action Partnership September 2019 to July 2022 As Scouts, we believe in preparing young people with skills for life. While building better futures, we contribute to society and bring
More informationProgram Agenda. 11:45 AM ET Registrants Join the Program Dial-in: (877) Log-in:
Program Agenda Tuesday, January 26, 2016 12:00 PM to 1:00 PM Eastern Time 11:00 AM to 12:00 PM Central Time 10:00 AM to 11:00 AM Mountain Time 9:00 AM to 10:00 AM Pacific Time 11:45 AM ET Registrants Join
More informationTo find a cure for Parkinson s
To find a cure for Parkinson s Our team 1 Anne-Marie Demoucelle FOUNDER & PRESIDENT anne-marie@demoucelle.com Patrick Demoucelle FOUNDER & IMPATIENT PATIENT patrick@demoucelle.com An-Heleen De Greef RELATIONS
More informationOverview on the symptoms, care and support of patients with PSP. Presented by: Gina Rutterford Development Officer East Anglia
The PSP Association Overview on the symptoms, care and support of patients with PSP Presented by: Gina Rutterford Development Officer East Anglia 1 PSP Play Station Portable? Other names Steele Richardson
More informationDeep Brain Stimulation. Is It Right for You?
Deep Brain Stimulation Is It Right for You? Northwestern Medicine Deep Brain Stimulation What is DBS? Northwestern Medicine Central DuPage Hospital is a regional destination for the treatment of movement
More information2018 WALK TO END HYDROCEPHALUS Twin Cities, MN SPONSORSHIP OPPORTUNITIES
2018 WALK TO END HYDROCEPHALUS Twin Cities, MN SPONSORSHIP OPPORTUNITIES WHAT IS HYDROCEPHALUS? Hydrocephalus is caused by an imbalance in the production and absorption of cerebral spinal fluid in the
More informationParkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD
Parkinson s Disease Initial Clinical and Diagnostic Evaluation J. Timothy Greenamyre, MD, PhD Involuntary tremulous motion, with lessened muscular power, in parts not in action and even when supported
More informationPostural instability Hypokinesia Rigidity Tremor Forward flexed posture. pain million people 50+ years old 10 most populated countries
4.1-4.6 million people 50+ years old 10 most populated countries Cyndi Robinson, PT, PhD University of Washington Seattle, Washington, USA Progressive neurodegenerative disorder Selective neuronal loss
More informationParkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle
Parkinson s Disease in the Elderly A Physicians perspective Dr John Coyle Overview Introduction Epidemiology and aetiology Pathogenesis Diagnosis and clinical features Treatment Psychological issues/ non
More informationClinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B.
UvA-DARE (Digital Academic Repository) Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B. Link to publication Citation for published version (APA): Post, B. (2009). Clinimetrics,
More informationJoint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD
Joint Session with ACOFP and Mayo Clinic Parkinson's Disease: 5 Pearls Jay Van Gerpen, MD Parkinson s Disease: 5 Pearls J.A. van Gerpen, MD Sections of Movement Disorders and Clinical Neurophysiology
More informationWelcome and Introductions
Spotlight on Parkinson s Disease Staying on Your Feet Balance Matters Tuesday, October 18, 2016 Welcome and Introductions Stephanie Paul Vice President Development and Marketing American Parkinson Disease
More informationANNUAL REPORT PWR! VISION Communities where individuals with Parkinson disease have access to Exercise as Medicine.
ANNUAL REPORT 2016 PWR! VISION Communities where individuals with Parkinson disease have access to Exercise as Medicine. PWR! MISSION To develop and implement worldwide access to Parkinson-specific neuroplasticity-principled
More informationCahaba Grand Conference Center Grandview Parkway Birmingham, AL. Senior Associate Director, Advancement, The Michael J.
Agenda Partners in Parkinson s Birmingham Cahaba Grand Conference Center 3660 Grandview Parkway Birmingham, AL Saturday, March 19, 2016 8 a.m.-2:30 p.m. 8 9 a.m. Registration and Breakfast 9 9:15 a.m.
More informationLet s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016
Let s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016 What is Parkinson s? Parkinson's is a progressive neurological condition. People
More informationExercise as Medicine The Role of Rehabilitation Professionals in Helping to Treat Parkinson's Disease Rehabilitation Services
Exercise as Medicine The Role of Rehabilitation Professionals in Helping to Treat Parkinson's Disease Katie Parafinczuk PT, DPT, NCS Redwood City, CA Rehabilitation Services My Background Kathleen.n.parafinczuk@kp.org
More informationScottish Clinical Leadership Fellowship About the SCLF
Scottish Clinical Leadership Fellowship About the SCLF Scottish Clinical Leadership Fellowship This guide introduces the Scottish Clinical Leadership Fellowship (SCLF) for doctors and dentists in training,
More informationAPDA Tulsa Optimism Walk 2018 Sponsorship Proposal
APDA Tulsa Optimism Walk 2018 Sponsorship Proposal CONTACT: Jennifer Johnson c: 918-849-5419 e: apdaok@apdaparkinson.org w: www.apdaparkinson.org/ok APDA Optimism Walk A fundraising event that offers a
More information10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.
Deep Brain Stimulation in the Treatment of Movement Disorders Disclosures None Eleanor K Orehek, M.D. Movement Disorders Specialist Noran Neurological Clinic 1 2 Objectives To provide an overview of deep
More informationCorporate Medical Policy
Corporate Medical Policy Dopamine Transporter Imaging with Single Photon Emission File Name: Origination: Last CAP Review: Next CAP Review: Last Review: dopamine_transporter_imaging_with_single_photon_emission_computed_tomography
More informationWhat are the Latest Treatment Advances in Parkinson disease
What are the Latest Treatment Advances in Parkinson disease Fatta B. Nahab, M.D. Associate Professor of Neurosciences Director, Functional Imaging of Neurodegenerative Disorders Lab Overview Recently approved
More informationDear Arizona Mental Health Criminal Justice Coalition Partner,
April 1, 2017 Dear Arizona Mental Health Criminal Justice Coalition Partner, David s Hope, a 501 (c )(3) nonprofit organization, was created in 2009, with the mission of reducing incarceration of those
More informationWhat is dementia. with Lewy bodies?
What is dementia with Lewy bodies? Contents 03 What is dementia with Lewy bodies? 04 Symptoms 05 Diagnosis 06 Treatments Information in this booklet is for anyone who wants to know more about dementia
More informationImproving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018
Improving diagnosis of Alzheimer s disease and lewy body dementia Brain TLC October 2018 Plan for this discussion: Introduction to AD and LBD Why do we need to improve diagnosis? What progress has been
More informationFactsheet on Children s Palliative Care at Jersey Hospice Care
Factsheet on Children s Palliative Care at Jersey Hospice Care 'The crux of our mission statement is as pertinent today as it ever was; to enable our patients to live the remainder of their lives to the
More informationDementia: It s Not Always Alzheimer s
Dementia: It s Not Always Alzheimer s A Caregiver s Perspective Diane E. Vance, Ph.D. Mid-America Institute on Aging and Wellness 2017 My Background Caregiver for my husband who had Lewy Body Dementia
More informationSPOTLIGHT ON MOVEMENT FUNCTION: COPING WITH ON/OFF PERIODS WELCOME AND INTRODUCTIONS
PARKINSON S DISEASE SPOTLIGHT ON MOVEMENT FUNCTION: COPING WITH ON/OFF PERIODS THURSDAY, MAY 11, 2017 WELCOME AND INTRODUCTIONS Stephanie Paul Vice President Development and Marketing American Parkinson
More informationParkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer
Press Release For Immediate Release October 30, 2017 Contact: Chris Di Salvo Mobile: (408) 506-0455 E-mail: profeff@aol.com Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist
More informationTHIS IS NOT YOUR GRANDMOTHER S DISEASE: WHAT DOES BEING DIAGNOSED WITH PARKINSON S DISEASE MEAN TODAY?
THIS IS NOT YOUR GRANDMOTHER S DISEASE: WHAT DOES BEING DIAGNOSED WITH PARKINSON S DISEASE MEAN TODAY? THURSDAY MARCH 14, 2019 REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA AMERICAN
More informationDifferential Diagnosis of Hypokinetic Movement Disorders
Differential Diagnosis of Hypokinetic Movement Disorders Dr Donald Grosset Consultant Neurologist - Honorary Professor Institute of Neurological Sciences - Glasgow University Hypokinetic Parkinson's Disease
More informationMovement and Memory. Undergraduate degree. Technology & Movement: New Approaches to Understanding Change. Graduate degree
Tracy Zitzelberger, MPH Technology & Movement: New Approaches to Understanding Change Tracy Zitzelberger, MPH Administra9ve Director Layton Aging & Alzheimer's Disease Center Oregon Center for Aging &
More informationSamantha K. Holden, MD East 17th Avenue Campus Box B185 Aurora, CO Phone:
EDUCATION Samantha K. Holden, MD University of Colorado Anschutz Medical Campus, Colorado Clinical and Translational Sciences Institute, Clinical Sciences Graduate Program, M.S. in Clinical Science. Expected
More informationPARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information
OHSU PARKINS ON CENTER Parkinson s Disease: Diagnosis and Management for Every MD Disclosure Information Grants/Research Support: National Parkinson Foundation, NIH, Michael J. Fox Foundation Consultant:
More informationAPDA Oklahoma Optimism Walk 2017 Sponsorship Proposal
APDA Oklahoma Optimism Walk 2017 Sponsorship Proposal CONTACT: Jenny Johnson c:918-849-5419 e:jjohnson@apdaparkinson.org w: www.apdaparkinson.org/oklahoma APDA Optimism Walk A fundraising event that offers
More informationWhat if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia
What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:
More informationMETHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE
METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE Madrid, 14 de noviembre de 2017 1. THE TEAM AND THE INSTITUTIONS BEHIND
More informationParkinson s Foundation
Parkinson s Foundation PD ExpertBriefing: Diagnosis PD, Now What? Managing the First Few Years with Parkinson s Led By: Suketu Khandhar, M.D., Medical Director at Kaiser Permanente Northern California
More informationSpeech and Voice Impairments in Individuals with PD. Jessica E. Huber, Ph.D. Associate Professor Purdue University
Speech and Voice Impairments in Individuals with PD Jessica E. Huber, Ph.D. Associate Professor Purdue University jhuber@purdue.edu Parkinson s Disease Progressive disorder which affects about 1 million
More informationParkinson s UK Brain Bank
Parkinson s UK Brain Bank From Brain to Breakthrough Dr George Gveric Manager 19 October 2018 Coordinated approach Donors Relatives Information Reporting Researchers Tissue supply Quality assurance Expertise
More informationCOMPANY TEAM CAPTAIN GUIDE
COMPANY TEAM CAPTAIN GUIDE The Alzheimer s Association is the world s leading voluntary health organization in Alzheimer s care, support and research. Our mission is to eliminate Alzheimer s disease through
More informationNon-therapeutic and investigational uses of non-invasive brain stimulation
Non-therapeutic and investigational uses of non-invasive brain stimulation Robert Chen, MA, MBBChir, MSc, FRCPC Catherine Manson Chair in Movement Disorders Professor of Medicine (Neurology), University
More informationParkinson s Disease Current Treatment Options
Parkinson s Disease Current Treatment Options Daniel Kassicieh, D.O., FAAN Sarasota Neurology, P.A. PD: A Chronic Neurodegenerative Ds. 1 Million in USA Epidemiology 50,000 New Cases per Year Majority
More informationreverse parkinsons BAD27E3FE044E25F3F8EBDA3B54333A9 Reverse Parkinsons 1 / 6
Reverse Parkinsons 1 / 6 2 / 6 3 / 6 Reverse Parkinsons Reverse Parkinson's Disease!-Take back your life! Do you want to improve your quality of life, when you have Parkinson's disease? Contrary to the
More informationDr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen. Dr. Michael Plopper. Dr. Guerry Peavy
1 Anne State 2 3 Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen Dr. Michael Plopper Dr. Guerry Peavy 4 Michael Lobatz, MD Medical Director, Neurosciences Medical Director, Rehabilitation
More informationMULTI SYSTEM ATROPHY: REPORT OF TWO CASES Dipu Bhuyan 1, Rohit Kr. Chandak 2, Pankaj Kr. Patel 3, Sushant Agarwal 4, Debjanee Phukan 5
MULTI SYSTEM ATROPHY: REPORT OF TWO CASES Dipu Bhuyan 1, Rohit Kr. Chandak 2, Pankaj Kr. Patel 3, Sushant Agarwal 4, Debjanee Phukan 5 HOW TO CITE THIS ARTICLE: Dipu Bhuyan, Rohit Kr. Chandak, Pankaj Kr.
More informationSMA Treatments and Clinical Trials. Kenneth Hobby, President Mary Schroth, MD, Chief Medical Officer Jill Jarecki, PhD, Chief Scientific Officer
SMA Treatments and Clinical Trials Kenneth Hobby, President Mary Schroth, MD, Chief Medical Officer Jill Jarecki, PhD, Chief Scientific Officer Agenda Introduction Kenneth Hobby, President Spinraza Update
More informationFebruary 23, Q4 and Year-End 2016 Financial Results
February 23, 2017 Q4 and Year-End 2016 Financial Results 2 RETHINKING CNS Agenda Today s Speakers Paul Cox, Senior Director, Investor Relations Jeff Jonas, M.D., Chief Executive Officer Jim Doherty, Ph.D.,
More informationOverview of Parkinson s disease Research at University of Colorado
Overview of Parkinson s disease Research at University of Colorado Brian D. Berman, MD, MS May 12, 2018 University of Colorado Movement Disorders Center Terminology Basic science pure/fundamental scientific
More information3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion
Alzheimer s and Dementia Research: An Advanced Discussion Brad Boeve, MD Department of Neurology Mayo Clinic Alzheimer s and Dementia Research: An Advanced Discussion Theoretical Constructs in Aging/Dementia
More informationEXERCISE FOR PARKINSON S RECOMMENDATIONS FOR MANAGING SYMPTOMS
EXERCISE FOR PARKINSON S RECOMMENDATIONS FOR MANAGING SYMPTOMS INSIDE THIS GUIDE EXERCISE FOR PARKINSON S OVERVIEW 3 RECOMMENDATIONS FOR EXERCISE FOR PARKINSON S 4 EXERCISE FOR PARKINSON S PRINCIPLES 5
More informationMoving Beyond Opioids for Chronic Pain
Back to the Future: Moving Beyond Opioids for Chronic Pain September 15-16, 2018 Hilton Richmond Hotel & Spa / Short Pump 12042 West Broad Street Presented by Departments of Anesthesiology and Physical
More information6/20/2012. Early Stage. Part 1. Learning objectives: Early-Stage Program. Understanding dementia. Understanding Alzheimer s disease
Learning objectives: Early-Stage Program Early Stage Objectives: Describe the symptoms of the early stage of Alzheimer s disease. Explain the legal, financial and resource planning that needs to be done
More informationParkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD
Parkinson s Disease: initial diagnosis, initial treatment & non-motor features J. Timothy Greenamyre, MD, PhD Involuntary tremulous motion, with lessened muscular power, in parts not in action and even
More information